Researchers from the Eaton-Peabody Laboratories of Massachusetts Eye and Ear and the Harvard Medical School/ Massachusetts Institute of Technology Program in Speech and Hearing Bioscience and Technology have revealed new understanding of the pathobiology behind a head and neck tumor that may someday lead to new methods of targeted drug therapy.
from The Medical News http://ift.tt/17GTNRd
from The Medical News http://ift.tt/17GTNRd
No comments:
Post a Comment